Abstract
To review the current clinical uses, ongoing investigations, and future applications of hematopoietic growth factors. Approved cytokines, as well as cytokines not yet released for general use, are included in this review. Clinical applications of granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and erythropoietin, the three recombinant hematopoietic growth factors currently commercially available for clinical use in the United States, are discussed. Macrophage colony-stimulating factor (M-CSF), interleukin-3 (IL-3), PIXY321, stem-cell factor (SCF), IL-1, IL-6, and IL-11 represent cytokines not yet approved; the majority of these newer agents have their principal action at an earlier time point in the hematopoietic cascade than the currently approved cytokines. Current clinical uses of hematopoietic growth factors include decreasing cytopenias associated with chemotherapy, those due to congenital or acquired bone marrow failure states, those that occur after high-dose chemotherapy and bone marrow transplantation, peripheral-blood progenitor mobilization, and supportive care of leukemia patients. Hematopoietic growth factors have made a significant impact on the prevention ...Continue Reading
Citations
Jan 1, 1997·Acta Oncologica·O Ringdén
Jul 1, 1998·International Reviews of Immunology·W S Alexander
Nov 28, 2001·Hematology·K M SullivanUNKNOWN American Society for Blood and Marrow Transplantation Practice Guidelines and beyond
Sep 1, 1997·Seminars in Surgical Oncology·W A See, C J Berman
Sep 19, 1998·Human Gene Therapy·G S HoggeE G MacEwen
Jan 19, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E VoogG Salles
Aug 24, 2000·Human Gene Therapy·T MatsunagaY Niitsu
May 20, 2003·Radiation Research·C Norman ColemanRosemary S L Wong
Mar 31, 2005·Phytotherapy Research : PTR·Rajesh AroraRakesh Kumar Sharma
May 1, 1997·Leukemia & Lymphoma·M ItäläK Remes
Jul 17, 1999·British Journal of Cancer·X H PeiN Hara
Apr 16, 1998·American Journal of Clinical Oncology·J NemunaitisD R Brocks
Apr 4, 2000·Bone Marrow Transplantation·S CharrierJ Chassagne
Jan 1, 1997·Stem Cells·N Dainiak, S Sorba
Jan 1, 1997·Pediatric Hematology and Oncology·D Schuler
May 2, 2000·Anti-cancer Drugs·B OlasA Buczyński
Jun 1, 2000·Bone Marrow Transplantation·O RingdénF Frassoni
Jul 22, 2005·The Cochrane Database of Systematic Reviews·E C SasseS Richards
Jan 1, 1998·Hematology·P JacobsR Schall
Jul 15, 2015·Free Radical Research·S KhanN K Chaudhury
Sep 1, 1999·British Journal of Haematology·M LejeuneE Sariban
Dec 3, 1999·Veterinary Surgery : VS·A E ChauvetD Lipsitz
May 8, 2000·Medical and Pediatric Oncology·U M Saarinen-PihkalaK Vettenranta
Jun 15, 1999·Toxicologic Pathology·J C Schuh, P J Morrissey
Dec 1, 1996·Journal of Hematotherapy·M J SchneidkrautC C Huntenburg
Jan 1, 1996·Vox Sanguinis·Y M Miller, H G Klein
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Curtis L CooperGary Garber
Apr 9, 2013·Journal of Tissue Engineering and Regenerative Medicine·Pedro Z AndradeCláudia L da Silva
Mar 21, 1997·The Journal of Biological Chemistry·R K TangiralaO Quehenberger
Jun 23, 2000·Journal of Pediatric Hematology/oncology·S K ParsonsJ Laver
Dec 27, 2008·Bulletin of Experimental Biology and Medicine·A M DygaiE D Goldberg
Jun 16, 2001·Hematology·CATHERINE M. VerfaillieRAVI Bhatia
May 1, 1996·Antimicrobial Agents and Chemotherapy·U Frank, H F Chambers
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
Oct 15, 2009·European Journal of Pharmacology·Andrzej SwierniakJaroslaw Smieja